Izotropic (OTCMKTS:IZOZF) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

by · The Cerbat Gem

Izotropic (OTCMKTS:IZOZF – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02), Zacks reports.

Izotropic Stock Performance

Shares of OTCMKTS IZOZF traded up $0.01 during midday trading on Monday, hitting $0.14. The stock had a trading volume of 12,386 shares, compared to its average volume of 22,122. The stock has a 50 day simple moving average of $0.17 and a 200-day simple moving average of $0.18. Izotropic has a 1 year low of $0.10 and a 1 year high of $0.37.

About Izotropic

(Get Free Report)

Izotropic Corporation is a medical technology company focused on developing advanced breast-imaging systems. Its primary product is the IzoView breast computed tomography (CT) system, which is designed to generate three-dimensional images of the breast and support the detection and evaluation of breast disease.

Unlike conventional mammography, the IzoView system is designed to image the breast without the same type of compression used in standard mammographic procedures. The company has also explored contrast-enhanced breast CT applications, with the goal of providing additional information for clinicians assessing suspicious findings and other breast conditions.

Izotropic is based in Richmond, British Columbia, Canada, and is focused on product development, clinical validation, regulatory activities and potential commercialization of its imaging technology.

Further Reading